A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new…
Category: clinical trials
AI, Biotech & Health, clinical trials, Global IT News, Global Security News, Grove AI, seed capital, Startups
Grove cuts clinical trial enrollment time with AI
Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic condition. Although she identified several promising trials, she found the sign-up process daunting — she had to have extensive email exchanges with clinical sites and complete lengthy 20-page forms. All that paperwork was so…